Is methylmalonic acid a functional marker of vitamin B12 status, but also affected by kidney dysfunction?

Methylmalonic acid (MMA) is a biologically grounded functional indicator of vitamin B12-dependent metabolism, but its diagnostic meaning is strongly modified by renal function—particularly relevant in older adults.

Clinical evidence

• MMA is most useful to clarify possible B12 deficiency when total or active B12 results are indeterminate and symptoms or signs are compatible. In adults with normal renal function, one diagnostic-accuracy study reported an AUC of 0.963; at an MMA threshold >229 nmol/L, sensitivity was 85.2% and specificity 92.3%.
• A value above 0.271 μmol/L (271 nmol/L) can suggest B12 deficiency, but no cutoff is universally applicable. Assay methods, laboratory reference ranges, age, kidney function, and the clinical presentation all affect interpretation.
• In a cohort of 1,533 older adults, lower eGFR and lower B12 were independently associated with higher MMA after adjustment for age and sex. Thus, reduced kidney function is not merely a coexisting feature of deficiency; it can independently raise circulating MMA.

Mechanistic basis

• B12 is converted to adenosylcobalamin, the essential cofactor for methylmalonyl-CoA mutase. When B12 availability is inadequate, mutase activity falls, methylmalonyl-CoA accumulates, and this is converted to MMA, increasing blood and urine MMA.
• With kidney dysfunction, reduced filtration and altered renal handling can contribute to MMA accumulation, reducing the marker’s specificity for impaired B12-dependent metabolism.

Practical interpretation

• MMA should not be used alone to diagnose B12 deficiency in a 70-year-old man, especially if eGFR is reduced. Interpret it alongside eGFR, total or active B12, symptoms, and other clinical findings.
• An eGFR-based correction model estimated that uncorrected MMA could overestimate deficiency by 40% among people with B12 concentrations of 90–300 pmol/L, although no correction method is universally accepted.

Bottom line

• The claim is well supported: MMA is a functional B12 marker, but kidney dysfunction can independently elevate it; an isolated elevation is insufficient to establish B12 deficiency when renal function is impaired.